Enzymatica AB (publ) (STO: ENZY)
Sweden
· Delayed Price · Currency is SEK 1.740
-0.040 (-2.25%)
Dec 2, 2024, 4:50 PM CET
Enzymatica AB Revenue
Enzymatica AB had revenue of 12.57M SEK in the quarter ending September 30, 2024, a decrease of -5.30%. This brings the company's revenue in the last twelve months to 44.25M, down -14.42% year-over-year. In the year 2023, Enzymatica AB had annual revenue of 50.90M with 4.00% growth.
Revenue (ttm)
44.25M
Revenue Growth
-14.42%
P/S Ratio
6.65
Revenue / Employee
2.60M
Employees
18
Market Cap
366.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 50.90M | 1.96M | 4.00% |
| Dec 31, 2022 | 48.95M | -8.30M | -14.49% |
| Dec 31, 2021 | 57.24M | -54.00M | -48.54% |
| Dec 31, 2020 | 111.25M | 49.94M | 81.46% |
| Dec 31, 2019 | 61.31M | 8.75M | 16.64% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 17.72B |